Lupus Erythematosus, Systemic
"Lupus Erythematosus, Systemic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow.
Below are MeSH descriptors whose meaning is more general than "Lupus Erythematosus, Systemic".
Below are MeSH descriptors whose meaning is more specific than "Lupus Erythematosus, Systemic".
This graph shows the total number of publications written about "Lupus Erythematosus, Systemic" by people in Harvard Catalyst Profiles by year, and whether "Lupus Erythematosus, Systemic" was a major or minor topic of these publication.
To see the data from this visualization as text, click here.
|Year||Major Topic||Minor Topic||Total|
Below are the most recent publications written about "Lupus Erythematosus, Systemic" by people in Profiles.
Risk of COVID-19 among unvaccinated and vaccinated patients with systemic lupus erythematosus: a general population study. RMD Open. 2023 03; 9(1).
Hydroxychloroquine Dose and Risk of Systemic Lupus Erythematosus Flares-Reply. JAMA. 2023 02 28; 329(8):686-687.
Construct validity of Patient-Reported Outcomes Measurement Information System Paediatric measures in juvenile idiopathic arthritis and systemic lupus erythematosus: cross-sectional evaluation. BMJ Open. 2023 01 27; 13(1):e063675.
Inhibitor of NF-?B Kinase Subunit e Contributes to Neuropsychiatric Manifestations in Lupus-Prone Mice Through Microglial Activation. Arthritis Rheumatol. 2023 03; 75(3):411-423.
The proliferative activity levels of each immune cell population evaluated by mass cytometry are linked to the clinical phenotypes of systemic lupus erythematosus. Int Immunol. 2023 01 21; 35(1):27-41.
Hydroxychloroquine Dose and Risk for Incident Retinopathy : A Cohort Study. Ann Intern Med. 2023 02; 176(2):166-173.
Safety of tacrolimus use during pregnancy and related pregnancy outcomes in patients with systemic lupus erythematosus: A retrospective single-center analysis in Japan. Lupus. 2023 Mar; 32(3):352-362.
New biologics and targeted therapies in systemic lupus: From new molecular targets to new indications. A systematic review. Joint Bone Spine. 2023 Mar; 90(2):105523.
A case report of two systemic lupus erythematosus pregnancies with early placental exposure to belimumab: Case report with review. Mod Rheumatol Case Rep. 2023 01 03; 7(1):82-86.
Dental caries and risk of newly-onset systemic lupus erythematosus: a nationwide population-based cohort study. Curr Med Res Opin. 2023 02; 39(2):307-317.